The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,056,390 in first-year total cost, median $698,720.
Most frequent study sections
- Special Emphasis Panel[ZCA1 RTRB-R (J1)]2
- Special Emphasis Panel[ZCA1 SRB-5 (O3)]1
Most frequent institutions
- EMORY UNIVERSITY1
- GEISINGER CLINIC1
- KAISER FOUNDATION RESEARCH INSTITUTE1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2020 | Feasibility and Assessment of a Cascade Traceback Screening program - FACTS1U01CA240747-01A1 | HENRIKSON, NORA B.JONAS, MARY CABELLRAHM, ALANNA K | GEISINGER CLINIC, PA | $703,016 | ZCA1 |
| 2020 | Leveraging tumor registries and pathology specimens to facilitate genetic testing and traceback for ovarian cancer1U01CA244323-01 | HUNTER, JESSICA EZZELL | KAISER FOUNDATION RESEARCH INSTITUTE, CA | $698,720 | ZCA1 |
| 2020 | Testing a Low Cost Population- and Theory-Based Outreach Intervention to Engage Ovarian Cancer Survivors and their Close Relatives to Consider Genetic Services1U01CA240581-01A1 | MC BRIDE, COLLEEN M | EMORY UNIVERSITY, GA | $654,654 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.